Pharmabiz14m
Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial
Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial: Columbus, Ohio Saturday, October 19, 2 ...
Pharmabiz1h
Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases
Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases: Cambridge, Massachusetts Saturday, October 1 ...
Pharmabiz2h
Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries
Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries: Winnipeg, Manitoba Saturday, October 19, 2024, 16:00 H ...
Pharmabiz3h
TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics
TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics: Tampa, Florida Saturday, October 19, 2024, 15:00 Hrs [IST] TuHURA Biosciences, a phase 3 r ...
Pharmabiz4h
Gland Pharma appoints Shyamakant Giri as new CEO
Gland Pharma’s board has approved the appointment of Shyamakant Giri as the new chief executive officer (CEO) of the company. Giri is to join the company with effect from January 15, 2025. Giri is a ...
Pharmabiz4h
Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities
Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities: Nivelles, Belgium Saturday, Oct ...
Pharmabiz5h
UK government to fund research into wearable technology, virtual reality and AI to support to cut drug deaths
UK government to fund research into wearable technology, virtual reality and AI to support to cut drug deaths: United Kingdom Saturday, October 19, 2024, 13:00 Hrs [IST] The UK go ...
Pharmabiz5h
Krishna Eye Centre unveils Contoura Vision Laser machine to comprehensively treat all eye related problems under one roof
Our Bureau, Mumbai Saturday, October 19, 2024, 12:30 Hrs [IST] ...
Pharmabiz6h
AbbVie’s Vyalev receives US FDA approval to treat adults living with advanced Parkinson's disease
North Chicago, Illinois Saturday, October 19, 2024, 12:00 Hrs [IST] ...
Pharmabiz6h
Dharmesh Kharwar joins Entod Pharmaceuticals as independent director
Dharmesh Kharwar joins Entod Pharmaceuticals as independent director: Our Bureau, Mumbai Saturday, October 19, 2024, 11:30 Hrs [IST] Mumbai-based Entod Pharmaceuticals has appoint ...
Pharmabiz7h
MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease
MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease: New York Saturday, October 19, 2024, 11:00 Hrs [IST] The Mic ...
Pharmabiz8h
Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024
Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024: Rahway, New Jersey Saturday, October ...